CSIMarket
 
Orthofix Medical Inc   (NASDAQ: OFIX)
Other Ticker:  
 
 
Price: $13.3050 $-0.11 -0.783%
Day's High: $13.55 Week Perf: -4.42 %
Day's Low: $ 13.21 30 Day Perf: -19.85 %
Volume (M): 20 52 Wk High: $ 20.73
Volume (M$): $ 269 52 Wk Avg: $16.17
Open: $13.55 52 Wk Low: $12.08



 Market Capitalization (Millions $) 508
 Shares Outstanding (Millions) 38
 Employees 1,271
 Revenues (TTM) (Millions $) 799
 Net Income (TTM) (Millions $) -126
 Cash Flow (TTM) (Millions $) 48
 Capital Exp. (TTM) (Millions $) 35

Orthofix Medical Inc
Orthofix Medical Inc. is a global medical device company that focuses on developing and distributing innovative solutions for musculoskeletal conditions. The company was founded in 1987 and is headquartered in Lewisville, Texas, USA. Its products are used in the areas of spine, trauma, sports medicine, extremities, and biologics.

Orthofix Medical's products and services are divided into two segments - Orthofix Spine and Orthofix Extremities. In total, the company has more than 600 employees and operates in over 70 countries, with global headquarters in Lewisville, Texas, and regional offices in Europe, Latin America, and Asia.

Orthofix Spine offers a wide range of spinal implant products, including spinal fusion systems for cervical, thoracolumbar, and lumbar spine surgeries. The company also offers vertebral compression fracture treatment, cervical disc replacement, and osteotomy systems for spinal deformity correction.

Orthofix Extremities focuses on medical devices for the upper and lower extremities, including external fixation systems, internal fixation systems, joint replacement and reconstruction, and biologic solutions for bone and tissue reconstruction. The company offers a full range of products for hand, wrist, elbow, foot, and ankle surgeries, as well as non-surgical treatments.

Orthofix Medical is committed to advancing the field of musculoskeletal medicine through research, innovation, and education. The company has invested heavily in research and development, and has established collaborative partnerships with leading physicians to develop new products and surgical techniques.

Orthofix Medical has received numerous awards and accolades for its products and services, including recognition by Forbes as one of America's best small companies, and recognition by the Orthopaedic Research and Education Foundation for its innovative research initiatives.

Overall, Orthofix Medical is a leading player in the global medical device industry, providing innovative solutions for musculoskeletal conditions and improving patients' quality of life.


   Company Address: 3451 Plano Parkway Lewisville 75056 TX
   Company Phone Number: 937-2000   Stock Exchange / Ticker: NASDAQ OFIX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EW        1.23% 
GMED   -2.6%    
MDT   -0.36%    
SYK   -1.08%    
TFX   -0.32%    
ZBH   -4.33%    
• View Complete Report
   



Announcement

Regulatory Scrutiny Dexcom, Orthofix, Spire Global, and Target Under InvestigationWhat Investors Need to Know

Published Wed, Dec 11 2024 7:11 PM UTC

On December 11, 2024, Johnson Fistel, LLP a prominent securities law firm announced an investigation into potential securities law violations involving key executives from a selection of publicly traded companies: Dexcom, Inc. (DXCM), Orthofix Medical Inc. (NASDAQ: OFIX), Spire Global, Inc. (NYSE: SPIR), and Target Corporation (NYSE: TGT). This alert serves as a wake-up call...

Announcement

Broken Brace Orthofix Medical?s Financial Misses and New Shareholder Battle Lines,

Published Wed, Oct 9 2024 4:34 PM UTC

Cracking the Case: Orthofix Medical?s Financial Fracture and Shareholder Turmoil In the labyrinth of healthcare investment, few tales grip the imagination quite like that of Orthofix Medical Inc. (NASDAQ: OFIX). This tale is not merely a narrative of financial metrics; it?s an evolving courtroom drama, catalyzed by the news that Levi & Korsinsky, LLP has alerted the investme...

Announcement

Orthofix Medicals Management Challenges A Legal Storm with Investor Implications,

Published Thu, Oct 3 2024 9:03 PM UTC

Navigating the Storm: Orthofix Medical Faces Legal Turmoil with Class Action LawsuitIn an unfolding legal narrative that has captured the attention of investors and financial markets alike, Orthofix Medical Inc. (NASDAQ: OFIX) finds itself entangled in a class action lawsuit that not only questions its management practices but also severely impacts its stock valuation. As t...

Announcement

Orthofix Medical Faces Securities Class Action Amidst Financial Losses and ROI Challenges

Published Thu, Sep 5 2024 4:40 PM UTC

In a recent notification, Levi & Korsinsky, LLP announced the filing of a securities class action on behalf of investors in Orthofix Medical Inc. (Orthofix or the Company). The case, filed on September 5, 2024, targets the healthcare company s lackluster financial performance and its impact on shareholders. This development comes in a tumultuous period for the company, marr...

Announcement

Orthofix Medical Inc. Faces Legal Turmoil as Shareholder Class Action Lawsuit Exposes Allegations of Misconduct

Published Thu, Aug 22 2024 3:07 PM UTC

In a development that has sent shockwaves throughout the financial and medical communities, Orthofix Medical Inc. (NASDAQ: OFIX) has found itself embroiled in a class-action lawsuit aimed at redressing alleged wrongdoings by its management team. This legal action, initiated by Holzer & Holzer, LLC, is particularly significant as it underscores not only the corporate governan...







Orthofix Medical Inc's Segments

  Orthofix Medical Inc Outlook

On November 8 2024 the Orthofix Medical Inc provided following guidance

nnOrthofix Medical Inc. Announces Third Quarter 2024 Results and Updates Financial Projectionsnn

nnLEWISVILLE, Texasnn - Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in global medical technology, has unveiled its financial outcomes for the third quarter ending September 30, 2024. The company has reaffirmed its financial guidance for the entire year and introduced new financial targets for the next three years.

### Key Highlights

In the third quarter of 2024, Orthofix reported net sales of $196.6 million, reflecting a robust increase of 7% when compared to the same period in 2023, whether assessed on a reported basis or in constant currency terms. Notably, the growth in ...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com